Il-10 signaling reduces survival in mouse models of synucleinopathy
Abstract Parkinson’s disease (PD) and related synucleinopathies are characterized by chronic neuroinflammation leading to the premise that anti-inflammatory therapies could ameliorate synucleinopathy and associated sequelae. To test this idea, we used recombinant adeno-associated viruses (AAV) to ex...
Guardado en:
Autores principales: | Samuel G. Cockey, Karen N. McFarland, Emily J. Koller, Mieu M. T. Brooks, Elsa Gonzalez De La Cruz, Pedro E. Cruz, Carolina Ceballos-Diaz, Awilda M. Rosario, Yona R. Levites, David R. Borchelt, Todd E. Golde, Benoit I. Giasson, Paramita Chakrabarty |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7d31e8435b0349f4ac0351ba14562121 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Amyloid β peptides overexpression in retinal pigment epithelial cells via AAV-mediated gene transfer mimics AMD-like pathology in mice
por: Tuhina Prasad, et al.
Publicado: (2017) -
Author Correction: IL-10 based immunomodulation initiated at birth extends lifespan in a familial mouse model of amyotrophic lateral sclerosis
por: Michael R. Strickland, et al.
Publicado: (2021) -
Autophagy in α-Synucleinopathies—An Overstrained System
por: Lisa Fellner, et al.
Publicado: (2021) -
Equine pituitary pars intermedia dysfunction: a spontaneous model of synucleinopathy
por: Jessica S. Fortin, et al.
Publicado: (2021) -
Comparative proteomic analysis highlights metabolic dysfunction in α-synucleinopathy
por: Souvarish Sarkar, et al.
Publicado: (2020)